Possible CDK4/6 inhibitor use in betel-nuts related head and neck squamous cell carcinoma(HNSCC).

被引:0
|
作者
Chen, Jo-Pai
Chang, Jui-Ying
Kuo, Sung Hsin
Hong, Ruey-Long
机构
[1] Natl Taiwan Univ Hosp, Yu Lin Branch, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[4] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
关键词
D O I
10.1200/JCO.2018.36.15_suppl.e18030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18030
引用
收藏
页数:1
相关论文
共 50 条
  • [41] LncRNAs as prognostic biomarkers in head and neck squamous cell carcinoma (HNSCC)
    Chaudhary, Ritu
    Wang, Xuefeng
    Cao, Biwei
    Gimbrone, Nicholas T.
    Slebos, Robbert J. C.
    Chung, Christine H.
    CANCER RESEARCH, 2019, 79 (13)
  • [42] Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
    F Lemaire
    R Millon
    J Young
    A Cromer
    C Wasylyk
    I Schultz
    D Muller
    P Marchal
    C Zhao
    D Melle
    L Bracco
    J Abecassis
    B Wasylyk
    British Journal of Cancer, 2003, 89 : 1940 - 1949
  • [43] Tumour stem cells in head and neck squamous cell carcinoma (HNSCC)
    Goldie, S. J.
    Watt, F. M.
    Price, R.
    ORAL ONCOLOGY, 2009, : 72 - 72
  • [44] PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).
    Da Costa, Alexandre Andre B. A.
    Costa, Felipe D'Almeida
    De Oliveira, Andrea Cruz Ferraz
    Stecca, Carlos
    Oliveira, Audrey
    Alves, Ana Caroline Fonseca
    Camandaroba, Marcos Pedro Guedes
    Araujo, Daniel Vilarim
    Machado, Larissa
    De Lima, Vladmir Claudio Cordeiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] TORS for head and neck squamous cell carcinoma (HNSCC): the Hamburg experience
    Loerincz, B. B.
    Knecht, R.
    B-ENT, 2015, 11 : 33 - 36
  • [46] Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
    Lemaire, F
    Millon, R
    Young, J
    Cromer, A
    Wasylyk, C
    Schultz, I
    Muller, D
    Marchal, P
    Zhao, C
    Melle, D
    Bracco, L
    Abecassis, J
    Wasylyk, B
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1940 - 1949
  • [47] Biomarkers of resistance to cetuximab in head and neck squamous cell carcinoma (HNSCC).
    Surikova, Ekaterina I.
    Kit, Oleg I.
    Neskubina, Irina V.
    Frantsiyants, Elena M.
    Vladimirova, Liubov Yu
    Lyanova, Aza A.
    Engibaryan, Marina A.
    Shalashnaya, Elena V.
    Aedinova, Irina V.
    Ulianova, Yulia V.
    Volkova, Viktoriya L.
    Pustovaya, Irina Viktorovna
    Ezhova, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines
    L. Zhang
    A. Gülses
    N. Purcz
    J. Weimer
    J. Wiltfang
    Y. Açil
    Clinical and Translational Oncology, 2019, 21 : 1052 - 1060
  • [49] The role of HOX genes in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Hunter, K.
    Hakami, F.
    Darda, L.
    Lambert, D.
    Murdoch, C.
    Morgan, R.
    Woll, P.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 177 - 177
  • [50] A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines
    Zhang, L.
    Guelses, A.
    Purcz, N.
    Weimer, J.
    Wiltfang, J.
    Acil, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (08): : 1052 - 1060